Recent series show a stroke rate of 0%Â to 3.5%, a cranial nerve injury rate of 5%-39%, and overall mortality of 0%-2.7%, with 15% of the patients unable to return to their preoperative daily activities.

With stereotactic radiosurgery treatment, 60% of the patients showed improvement of previous neurological deficits. Tumor control is obtained in 91% of the patients.